RLMD Chart
- 52-Week Range: $16.72 - $34.77
- Market Capitalization: $587.52M
- Short Percentage: 0%
- Target Price: $60.43
- Shares Outstanding: 29.99M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RLMD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 23rd
- Relmada Therapeutics to Participate in Fireside Chats at Two Upcoming Healthcare EventsPRNewsWire | March 10th
- Relmada Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare ConferencePRNewsWire | February 10th
- Relmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment OptionPRNewsWire | December 14th
- Relmada Stock Falls After Equity Raise Of $150M To Fund Depression CandidateBenzinga | December 9th
- Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common StockPRNewsWire | December 8th
- Relmada Therapeutics Announces Proposed Public Offering of Common StockGlobeNewsWire | December 8th
Company Info
Website: https://www.relmada.com
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 10
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL, United States, 33134
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 10
$RLMD up we go
$RLMD oversold! Buy the dip
$RLMD BUY BUY BUY
$RLMD oversold! Buy the dip
$RLMD Who else bought the dip on Friday?
$RLMD all in
$RLMD nice!!!
$RLMD starting to gap up a little
$RLMD i like the stock
$RLMD bag holders for life club